Exploiting the enhanced permeability and retention effect for tumor targetingArun K. Iyer, Hiroshi Maeda, Jun Fang et al.|Drug Discovery Today|2006Cited by 1.8k
Macromolecular TherapeuticsKhaled Greish, Hiroshi Maeda, Jun Fang et al.|Clinical Pharmacokinetics|2003Cited by 279
A combination of tyrosine kinase inhibitors, crizotinib and dasatinib for the treatment of glioblastoma multiformeHayley Nehoff, Khaled Greish|Oncotarget|2015Cited by 32
A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancerSébastien Taurin, Khaled Greish|International Journal of Nanomedicine|2016Cited by 20